|
Market Closed -
Other stock markets
|
After hours 10:00:00 am | |||
| 355.25 USD | -1.44% |
|
345.94 | -2.62% |
| 14/07 | BofA Securities Adjusts Amgen Price Target to $312 From $307 | MT |
| 14/07 | UBS Adjusts Price Target on Amgen to $420 From $400, Maintains Buy Rating | MT |
Company Valuation: Amgen Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 126,718 | 140,139 | 154,142 | 140,103 | 176,250 | 191,731 | - | - |
| Change | - | 10.59% | 9.99% | -9.11% | 25.8% | 8.78% | - | - |
| Enterprise Value (EV) 1 | 151,990 | 169,779 | 207,811 | 188,229 | 221,725 | 233,673 | 228,022 | 223,299 |
| Change | - | 11.7% | 22.4% | -9.42% | 17.8% | 5.39% | -2.42% | -2.07% |
| P/E | 21.9x | 21.7x | 23.1x | 34.5x | 23x | 23.3x | 21.4x | 20.5x |
| PBR | 18.7x | 38.3x | 24.7x | 23.8x | 20.4x | 17.9x | 15x | 12.4x |
| PEG | - | 1.2x | 7.36x | -0.9x | 0.3x | 3.26x | 2.36x | 5.12x |
| Capitalization / Revenue | 4.88x | 5.32x | 5.47x | 4.19x | 4.8x | 5.08x | 4.96x | 4.83x |
| EV / Revenue | 5.85x | 6.45x | 7.37x | 5.63x | 6.03x | 6.19x | 5.9x | 5.62x |
| EV / EBITDA | 9.61x | 10.5x | 11.9x | 9.13x | 10.4x | 10.9x | 10.6x | 10.7x |
| EV / EBIT | 12.2x | 13.3x | 15.5x | 12.5x | 13.7x | 14.2x | 13.4x | 12.8x |
| EV / FCF | 18.1x | 19.3x | 28.2x | 18.1x | 27.4x | 18.4x | 15.1x | 14.6x |
| FCF Yield | 5.51% | 5.17% | 3.54% | 5.52% | 3.65% | 5.43% | 6.63% | 6.83% |
| Dividend per Share 2 | 7.04 | 7.76 | 8.52 | 9 | 9.52 | 10.09 | 10.66 | 11.12 |
| Rate of return | 3.13% | 2.95% | 2.96% | 3.45% | 2.91% | 2.84% | 3% | 3.13% |
| EPS 2 | 10.28 | 12.11 | 12.49 | 7.56 | 14.23 | 15.25 | 16.63 | 17.29 |
| Distribution rate | 68.5% | 64.1% | 68.2% | 119% | 66.9% | 66.2% | 64.1% | 64.3% |
| Net sales 1 | 25,979 | 26,323 | 28,190 | 33,424 | 36,751 | 37,743 | 38,668 | 39,735 |
| EBITDA 1 | 15,822 | 16,178 | 17,470 | 20,620 | 21,370 | 21,359 | 21,472 | 20,861 |
| EBIT 1 | 12,424 | 12,761 | 13,399 | 15,028 | 16,203 | 16,491 | 16,983 | 17,474 |
| Net income 1 | 5,893 | 6,552 | 6,717 | 4,090 | 7,711 | 8,219 | 8,851 | 9,284 |
| Net Debt 1 | 25,272 | 29,640 | 53,669 | 48,126 | 45,475 | 41,942 | 36,290 | 31,568 |
| Reference price 2 | 224.97 | 262.64 | 288.02 | 260.64 | 327.31 | 355.25 | 355.25 | 355.25 |
| Nbr of stocks (in thousands) | 563,266 | 533,579 | 535,178 | 537,533 | 538,481 | 539,708 | - | - |
| Announcement Date | 7/2/22 | 31/1/23 | 6/2/24 | 4/2/25 | 3/2/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 23.3x | 6.19x | 10.94x | 2.84% | 192B | |
| 34.25x | 12.25x | 25.43x | 0.59% | 1,028B | |
| 27.09x | 6.22x | 16.9x | 2.1% | 611B | |
| 30.33x | 7.27x | 14.9x | 2.81% | 432B | |
| 17.47x | 4.34x | 10.68x | 3.06% | 323B | |
| 21.17x | 5.44x | 13.17x | 2.9% | 277B | |
| 20.69x | 4.37x | 12.08x | 2.02% | 257B | |
| 13.99x | 5.26x | 10.84x | 3.55% | 217B | |
| -46.85x | 5.61x | 31x | 2.5% | 161B | |
| 12.32x | 3.04x | 7.69x | 7.12% | 138B | |
| Average | 15.38x | 6.00x | 15.36x | 2.95% | 363.65B | |
| Weighted average by Cap. | 22.92x | 7.49x | 17.50x | 2.23% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- AMGN Stock
- Valuation Amgen Inc.
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
